Filing Overview
Registrant: Complete Solaria, Inc. (the request identifies SunPower Inc.; the filing itself names Complete Solaria, Inc.). This Form 8-K was signed April 22, 2024, with an earliest reported event date of April 16, 2024. The filing does not report periodic operating results.
Material Financing and Capitalization
- On April 21, 2024, the company amended two Simple Agreements for Future Equity (SAFE) instruments with trusts associated with Rodgers Massey Freedom and Free Markets Charitable Trust.
- The first amendment relates to a $1.5 million investment and is convertible into a maximum of 4,166,667 common shares at an assumed conversion price of $0.36 per share.
- The second amendment relates to a $3.5 million investment and is convertible into a maximum of 9,722,222 common shares at an assumed conversion price of $0.36 per share.
- Total stated financing is $5.0 million, with a potential maximum issuance of 13,888,889 common shares based on the filing’s assumptions. The conversion price represents 80% of the April 19, 2024 closing price of $0.45.
- Thurman J. Rodgers is a trustee of the purchaser and the company’s Executive Chairman, making the transactions related-party financings.
- The company reported the securities as issued under an exemption from registration under Section 4(a)(2) and/or Rule 506(b) of Regulation D.
Nasdaq Listing Deficiencies
- Minimum bid price: Nasdaq notified the company on April 16, 2024 that its common stock had failed to maintain the required $1.00 minimum bid price for 30 consecutive business days.
- The company has until October 14, 2024 to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days. A further 180-day period may be available if additional conditions are met, potentially involving a reverse stock split.
- Market value of listed securities: Nasdaq separately notified the company that its common stock had traded below the $50 million minimum market value of listed securities requirement for 30 consecutive trading days.
- The company also has until October 14, 2024 to regain compliance by maintaining market value of listed securities of at least $50 million for at least 10 consecutive business days. Transfer to the Nasdaq Capital Market may be available if its requirements are satisfied.
- Both notices were described as deficiency notifications and did not immediately affect the listing or trading of the securities. Failure to cure could result in delisting proceedings, subject to potential appeal.
Financial Metrics and Outlook
The filing does not provide revenue, profit, cash flow, operating margins, debt balances, liquidity balances, historical-period comparisons, or formal financial guidance. Management stated that it intends to monitor the stock price and market value of listed securities and evaluate available actions to regain compliance, but cautioned that there is no assurance the company will regain or maintain Nasdaq compliance.
Key Investor Verification Items
- Confirm the final conversion terms, timing, and actual number of common shares issued under the two SAFE amendments.
- Assess dilution from the potential issuance of up to 13,888,889 shares and the related-party nature of the financings.
- Monitor whether the company satisfies both the $1.00 minimum bid price and $50 million market value requirements by October 14, 2024.
- Review any subsequent reverse-stock-split proposal, Nasdaq transfer, delisting notice, or appeal.
- Reconcile the filing’s event dates: the report identifies April 16 as the earliest event date, while the SAFE amendments are dated April 21 and the report was signed April 22.